Skip to main content

Brugada Syndrome : Rare inherited cardiovascular disorder

Brugada Syndrome

Summary
Brugada syndrome is a rare inherited cardiovascular disorder characterized by disturbances affecting the electrical system of the heart. The main symptom is irregular heartbeats and, without treatment, may potentially result in sudden death. Recent reports suggest that Brugada syndrome could be responsible up to 20% of sudden death in patients with structurally normal hearts. The clinical phenotype manifests in adulthood, and it is more frequent in males. Frequently, sudden death can be the first manifestation of the disease. Brugada syndrome is a genetic disease and follows autosomal dominant inheritance. Currently, the prevalence of Brugada syndrome is estimated at 5 in 10,000 people.

For More Detailed note on Brugada syndrome Click on the Following link 


Submit Your Research work Related to the Cardiology as Abstract, Present and Participate in the Summit Heart Diseases Summit 2020 April 20-21,2020

Discussion on various topics on Heart Diseases Carried out at  https://heartdiseases.conferenceseries.com/asiapacific/

For more details 
Contact 
Samanta Grace 
Program Manager 

Note : here we provide the Info that is there in various Platforms,we Do not Copyright we just Publish it For create Awareness on the topics 


Comments

Popular posts from this blog

4th Global Summit on Heart Diseases March 15-16, 2019 Singapore

About Conference After the splendid success of “ 2 nd  World Heart Congress ” held at Tokyo, Japan during May 14-16, 2018 we proudly announce the " 4 th  Global Summit on Heart Diseases " which will be held during  March 15-16, 2019  at  Singapore . Access to all Scientific Sessions (Keynotes, Plenary, Workshops, Symposiums, Poster Presentations) Get participation certificate from Heart Diseases Summit 2018 Organising Committee Members You can make contacts with eminent keynote speakers and research professionals for your career growth. Get 5 star hospitality at the conference venue  B 2 B Meeting with the Companies Access to all Scientific Sessions (Keynotes, Plenary, Workshops, Symposiums, Poster Presentations) Full Conference Kit with Conference Souvenir and Final Program (e-copies) Abstracts will be published in the conference souvenir and respective International journals Each Abstract will receive unique (DOI) Number provided by Cross

Classification of Cardiovascular Drugs

Classification of Cardiovascular Drugs The hashtag # Cardiovascular_Drugs Cardiovascular agents are medicines that are used to treat medical conditions associated with the heart or the circulatory system (blood vessels), such as arrhythmias, blood clots, coronary artery disease, high or low blood pressure, high cholesterol, heart failure, and stroke. Discuss on Various Classification of Cardiovascular Drugs and their Novel Developments at the Heart Diseases Summit 2020 on april 20-21,2020 Discussion on various topics on Heart Diseases Carried out at  https://heartdiseases.conferenceseries.com/asiapacific/ For more details  Contact  Samanta Grace  Program Manager  heartdiseases@asiameets.com website :  https://heartdiseases.conferenceseries.com/asiapacific/ hashtag # cardiovascular hashtag # cardiovascular hashtag # cardiology hashtag # diabetes hashtag # cancer hashtag # cardiovascular_disease hashtag # heart_disease hashtag # heart_diseases hashtag #
                                                              Global Summit on Heart Diseases April 20-21, 2020 | Kyoto, Japan Theme: Accelerated action to prevent the Cardiovascular diseases